Literature DB >> 10799313

Sustained enhancement of Ca(2+) influx by glibenclamide induces apoptosis in RINm5F cells.

T Iwakura1, S Fujimoto, S Kagimoto, A Inada, A Kubota, Y Someya, Y Ihara, Y Yamada, Y Seino.   

Abstract

Cytosolic Ca(2+) elevations are known to be involved in triggering apoptosis in many tissues, but the effect of sustained enhancement of Ca(2+) influx on apoptosis in beta cells remains unknown. We have found that the viability of RINm5F cells is decreased dose-dependently by continuous exposure to glibenclamide at concentrations from 10(-7) to 10(-4) M, and that this effect is partially ameliorated by pretreatment with cycloheximide. Electrophoresis of the cells exposed to glibenclamide revealed ladder-like fragmentation characteristic of apoptosis, and which also is suppressed by cycloheximide pretreatment. By using terminal deoxynucleotidyl transferase-mediated dUTP nick end-labeling (TUNEL) staining, we detected increased DNA fragmentation in the nuclei of the cells exposed to glibenclamide, and staining with Hoechst 33342 and propidium iodide showed a dose-dependent increase in the number of cells with the chromatin condensation and fragmentation in their nuclei that is characteristic of apoptosis. The effects of glibenclamide on cell viability and apoptotic cell death were partially inhibited by treatment with Ca(2+) channel blocker, and by reducing the extracellular Ca(2+) concentration during glibenclamide exposure, suggesting that they may be derived from increased Ca(2+) influx. Furthermore, only the percentage of apoptotic cells, and not that of necrotic cells, increased with the increasing intracellular Ca(2+) concentration during glibenclamide exposure. In conclusion, we have demonstrated that the sustained enhancement of Ca(2+) influx caused by glibenclamide exposure can induce apoptotic cell death in a pure beta cell line. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10799313     DOI: 10.1006/bbrc.2000.2616

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  14 in total

1.  Fluctuation-driven mechanotransduction regulates mitochondrial-network structure and function.

Authors:  Erzsébet Bartolák-Suki; Jasmin Imsirovic; Harikrishnan Parameswaran; Tyler J Wellman; Nuria Martinez; Philip G Allen; Urs Frey; Béla Suki
Journal:  Nat Mater       Date:  2015-07-27       Impact factor: 43.841

2.  Endoplasmic reticulum stress in diabetes: New insights of clinical relevance.

Authors:  Muthuswamy Balasubramanyam; Raji Lenin; Finny Monickaraj
Journal:  Indian J Clin Biochem       Date:  2010-05-27

3.  The Time Is Right for a New Classification System for Diabetes: Rationale and Implications of the β-Cell-Centric Classification Schema.

Authors:  Stanley S Schwartz; Solomon Epstein; Barbara E Corkey; Struan F A Grant; James R Gavin; Richard B Aguilar
Journal:  Diabetes Care       Date:  2016-02       Impact factor: 19.112

4.  The TRPA1 channel and oral hypoglycemic agents: is there complicity in β-cell exhaustion?

Authors:  Carlos Manlio Diaz-Garcia
Journal:  Channels (Austin)       Date:  2013-08-06       Impact factor: 2.581

5.  Transfection of rat pancreatic islet tissue by polymeric gene vectors.

Authors:  Han Chang Kang; You Han Bae
Journal:  Diabetes Technol Ther       Date:  2009-07       Impact factor: 6.118

6.  Protective role of glibenclamide against nicotinamide-streptozotocin induced nuclear damage in diabetic Wistar rats.

Authors:  Syed Imam Rabbani; Kshama Devi; Salma Khanam
Journal:  J Pharmacol Pharmacother       Date:  2010-01

7.  Gliclazide may have an antiapoptotic effect related to its antioxidant properties in human normal and cancer cells.

Authors:  Agnieszka Sliwinska; Aneta Rogalska; Marzena Szwed; Jacek Kasznicki; Zofia Jozwiak; Jozef Drzewoski
Journal:  Mol Biol Rep       Date:  2011-12-20       Impact factor: 2.316

8.  Multi-Tissue Acceleration of the Mitochondrial Phosphoenolpyruvate Cycle Improves Whole-Body Metabolic Health.

Authors:  Abudukadier Abulizi; Rebecca L Cardone; Romana Stark; Sophie L Lewandowski; Xiaojian Zhao; Joelle Hillion; Lingjun Ma; Raghav Sehgal; Tiago C Alves; Craig Thomas; Charles Kung; Bei Wang; Stephan Siebel; Zane B Andrews; Graeme F Mason; Jesse Rinehart; Matthew J Merrins; Richard G Kibbey
Journal:  Cell Metab       Date:  2020-11-03       Impact factor: 27.287

9.  Glibenclamide inhibits cell growth by inducing G0/G1 arrest in the human breast cancer cell line MDA-MB-231.

Authors:  Mariel Núñez; Vanina Medina; Graciela Cricco; Máximo Croci; Claudia Cocca; Elena Rivera; Rosa Bergoc; Gabriela Martín
Journal:  BMC Pharmacol Toxicol       Date:  2013-01-11       Impact factor: 2.483

10.  Hypoglycemic and beta cell protective effects of andrographolide analogue for diabetes treatment.

Authors:  Zaijun Zhang; Jie Jiang; Pei Yu; Xiangping Zeng; James W Larrick; Yuqiang Wang
Journal:  J Transl Med       Date:  2009-07-16       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.